Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

TSX:QIPT - Post Discussion

Quipt Home Medical Corp > New Press Release - Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%
View:
Comment by Peanuts3 on May 15, 2024 5:50pm
Bad news over bad news... And the company siad a few days ago... the company is undervalued... B.S.
Comment by Possibleidiot01 on May 15, 2024 7:08pm
What am I failing to see in the results which look fairly good to me?. The other down thing I noticed is the reimbursement setup being changed. And that change is built into the results. "Revenue for Q2 2024 was $64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase. Organic growth contributed approximately $3.3 million, or 6% on an annual basis. The Company ...more  
Comment by Peanuts3 on May 15, 2024 7:18pm
yeah for one and the second: more and more revenue and minus eps (more) again
Comment by Possibleidiot01 on May 15, 2024 8:22pm
Ah, missed that sentence. "Net income (loss) for Q2 2024 was $(1.4) million, or ($0.03) per diluted share, as compared to $(0.7) million, or $(0.02) per diluted share for Q2 2023. Thanks. Maybe partially explained by "recent cyber-attack on Change Healthcare, which impacted the ability to process and bill claims in the back half of the quarter. The Company expects cash collections to ...more  
Comment by lscfa on May 15, 2024 9:48pm
net income impacted by $1M spent on legal for DOJ investigation.